Category - Feature

Feature

Likarda seeks acquisition partner to accelerate cell therapy delivery breakthrough

Closely held Likarda is advancing a novel modality for delivering cellular therapies—a proprietary, customizable hydrogel delivery system engineered for controlled release, immune protection, and high cell viability.

September 2, 2025

Feature

Solu developing a powerful new therapeutic modality that unlocks cell surface targets

Closely held Solu Therapeutics is pairing heterobifunctional small molecules with monoclonal antibodies to develop therapeutic agents that eliminate disease-driving cells in cancer, immunology, and other therapeutic...

August 19, 2025

Feature

Ascentage reviving programmed cell death with novel approach to hematologic malignancies

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) is advancing its proprietary drug discovery platform of first- and best-in-class small molecule therapies to address unmet medical needs in cancers and other diseases.

August 12, 2025

Feature

Light AI turning smartphones into portable diagnostic labs for infectious disease detection

Light AI (CBOE CA: ALGO; FSE: 0H6; OTCQB: OHCFF) is developing cutting-edge artificial intelligence (AI) to advance health diagnostics and wellness solutions through its proprietary technology platform. By applying AI...

August 5, 2025

Feature

Bioxytran disrupting infectious disease and inflammation with carbohydrate-based therapeutics

Bioxytran Inc. (OTCQB: BIXT) is pioneering the use of complex carbohydrate-based therapeutics to address urgent unmet medical needs in virology, cancer metastasis, and oxygen transport.

July 29, 2025

Feature

Nimbus designing potential best-in-class small molecule medicines for difficult-to-drug targets

Closely held Nimbus Therapeutics is designing and developing precisely tailored small molecule medicines for challenging targets by leveraging a unique strategy that combines computational chemistry technologies with...

July 22, 2025

Feature

EsoBiotec unlocking new possibilities for oncology and autoimmune disease by empowering cells in vivo

Closely held EsoBiotec is transforming cell therapy by engineering immune cells directly within a patient’s body, enabling the immune system to attack disease—potentially delivering cell therapy to patients in minutes...

July 15, 2025

Feature

Dotmatics empowering life-changing discoveries with next-gen therapeutic research solution

Closely held Dotmatics is transforming the therapeutic research and development landscape with Luma, a groundbreaking solution in multimodal data management with the potential to address long-standing scientific...

July 1, 2025

Feature

VeriSIM delivering predictive insights to advance and de-risk drug development

Closely held VeriSIM Life is leveraging multi-disciplinary quantitative methods to predict patient outcomes and accelerate the discovery, development, and commercialization of transformative therapies. The company aims...

June 24, 2025

Feature

Launchit Solutions enhancing patient outcomes through strategic partnerships and advanced medical programs

Launchit Solutions is leveraging breakthrough technology and clinically validated innovations to bring effective healthcare solutions to patients, with a focus on obesity management, support programs, life science...

June 17, 2025

Category - Feature

Subscribe